Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axis.
about
Combined targeting of SET and tyrosine kinases provides an effective therapeutic approach in human T-cell acute lymphoblastic leukemia.Reprogramming the oncogenic response: SET protein as a potential therapeutic target in cancer.SET oncoprotein accumulation regulates transcription through DNA demethylation and histone hypoacetylation.PP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast Cancer.Small molecule activators of protein phosphatase 2A for the treatment of castration-resistant prostate cancer.
P2860
Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Inhibition of Pten deficient C ...... the SET - PP2A Signaling axis.
@ast
Inhibition of Pten deficient C ...... the SET - PP2A Signaling axis.
@en
type
label
Inhibition of Pten deficient C ...... the SET - PP2A Signaling axis.
@ast
Inhibition of Pten deficient C ...... the SET - PP2A Signaling axis.
@en
prefLabel
Inhibition of Pten deficient C ...... the SET - PP2A Signaling axis.
@ast
Inhibition of Pten deficient C ...... the SET - PP2A Signaling axis.
@en
P2093
P2860
P356
P1433
P1476
Inhibition of Pten deficient C ...... the SET - PP2A Signaling axis.
@en
P2093
Consuelo Garcia
Dale Christensen
David J Mulholland
Ladan Fazli
Marilyn Jansen
Martin Gleave
Michael P Vitek
Xiaoyong Hu
P2860
P2888
P356
10.1038/SREP15182
P407
P577
2015-11-13T00:00:00Z